ARCHIVES

October issue of Business & Regulatory Report (8-page issue).

This article is from The Cancer Letter archive.

Vol. 28 No. 40 | November 2, 2002

Download PDF Visit The Full Archive

Related Articles

President’s Cancer Panel urges comprehensive health care reform, provision of services for cancer survivors.

June 4, 2004

Lilly Suspends Phase III Trial Of Tasisulam in Melanoma

January 28, 2011

NCI Seeks to Maintain Grant Success Rate As Budget Deadlock Deepens on Capitol Hill

April 25, 2013

Terry To Leave As DRCCA Acting Director Sept. 1, Peter Greenwald Is DeVita’s Choice For The Job

August 14, 1981

NCI Cooperative Group, Cancer Center Trials Listed

November 25, 2005

FDA Announces Plan to Reform Drug Approval, Hire Outside Experts To Handel Some Reviews

November 22, 1991